despite adequate iron excretion as a result of subcutaneous desferrioxamine ( dfo ) infusions , the patients showed significant iron overload , which suggested poor compliance in the home use of dfo and was the main long-term problem in the treatment of beta-thalassaemia major .
C0282193
iron overload
C0011145
dfo